Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK2 | P49760 | 15/20 | 0.67 |
| ▸ | CLK3 | P49761 | 13/20 | 0.67 |
| ▸ | DYRK1A | Q13627 | 13/20 | 0.67 |
| ▸ | WNT1 | P04628 | 6/20 | 0.61 |
| ▸ | TGFBR1 | P36897 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21283933 | 0.93 | CLK2 (0.77) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18480517 | 0.91 | WNT1 (0.64) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18480884 | 0.90 | CLK2 (0.63) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18438332 | 0.89 | CLK2 (0.68) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18438649 | 0.89 | CLK2 (0.77) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18438921 | 0.89 | CLK2 (0.67) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18438727 | 0.87 | CLK2 (0.65) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18480881 | 0.87 | CLK2 (0.63) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18480893 | 0.87 | CLK2 (0.72) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL18438331 | 0.87 | WNT1 (0.73) | CLK2CLK3DYRK1AWNT1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017023989-A1 | 3-(1H-BENZO[D]IMIDAZOL-2-YL)-1H-PYRAZOLO[4,3-B]PYRIDINES AND THERAPEUTIC USES THEREOF | SAMUMED, LLC. (US) | 2017-02-09 | — | — | WO | disclosed |